SCHEMBL8338253

SCHEMBL8338253

CC(=O)Nc1ccc(NC(=O)c2cc3cc(N)ccc3n2Cc2ccccc2F)cc1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8334899 0.92 ECE1 (0.68) ECE1
SCHEMBL8362921 0.89 ECE1 (0.61) ECE1
SCHEMBL8362876 0.88 ECE1 (0.58) ECE1
SCHEMBL6019416 0.87 ECE1 (0.63) ECE1
SCHEMBL8334902 0.86 ECE1 (0.61) ECE1
SCHEMBL6175113 0.85 ECE1 (0.63) ECE1
SCHEMBL8362919 0.84 ECE1 (0.59) ECE1
SCHEMBL8362939 0.84 ECE1 (0.90) ECE1
SCHEMBL8330098 0.83 ECE1 (0.88) ECE1
SCHEMBL6019336 0.82 ECE1 (0.52) ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004056768-A2 USE OF SUBSTITUTED 2,5-DIAMIDOINDOLES FOR THE TREATMENT OF UROLOGICAL DISEASES BAYER HEALTHCARE AG (DE) 2004-07-08 WO disclosed